Package 60505-6272-1

Brand: irinotecan hydrochloride

Generic: irinotecan hydrochloride
NDC Package

Package Facts

Identity

Package NDC 60505-6272-1
Digits Only 6050562721
Product NDC 60505-6272
Product ID 60505-6272_c313857d-e43f-4500-8766-6037fb68ad9e
Description

1 VIAL, SINGLE-USE in 1 CARTON (60505-6272-1) / 5 mL in 1 VIAL, SINGLE-USE

Marketing

Marketing Status
Marketed Since 2023-07-01
Brand irinotecan hydrochloride
Generic irinotecan hydrochloride
Sample Package No

Linked Drug Pages (1)

Irinotecan Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "c313857d-e43f-4500-8766-6037fb68ad9e", "openfda": {"unii": ["042LAQ1IIS"], "rxcui": ["1726324"], "spl_set_id": ["8fe98987-e526-4729-a8f4-c7230f424108"], "manufacturer_name": ["Apotex Corp."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (60505-6272-1)  / 5 mL in 1 VIAL, SINGLE-USE", "package_ndc": "60505-6272-1", "marketing_start_date": "20230701"}], "brand_name": "Irinotecan Hydrochloride", "product_id": "60505-6272_c313857d-e43f-4500-8766-6037fb68ad9e", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Topoisomerase Inhibitor [EPC]", "Topoisomerase Inhibitors [MoA]"], "product_ndc": "60505-6272", "generic_name": "Irinotecan Hydrochloride", "labeler_name": "Apotex Corp.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Irinotecan Hydrochloride", "active_ingredients": [{"name": "IRINOTECAN HYDROCHLORIDE", "strength": "20 mg/mL"}], "application_number": "ANDA203380", "marketing_category": "ANDA", "marketing_start_date": "20230701", "listing_expiration_date": "20261231"}